Bpifrance

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors

Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke

Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment

Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers

Develops small-molecule therapies for targeted protein degradation at the point of synthesis